In recent years, many neurodegenerative diseases have been correlated to the dysfunction of N-methyl-D-aspartate receptors (NMDARs)-mediated neurotransmission. Drugs that directly affect the activity of the receptors evoke strong responses and typically show severe side effects. In this framework, serine racemase (SR) – the enzyme responsible for D-serine production in the brain – was suggested as an alternative therapeutic target. The detailed characterization of human SR (hSR) is currently rather limited, with a few published biochemical studies that provides a limited insight into the understanding of its regulation mechanisms. This work was aimed at achieving a more complete characterization of hSR dynamics, function and regulatory prop...